Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 10 | 2024 | 1014 | 2.570 |
Why?
|
| Acute-On-Chronic Liver Failure | 3 | 2023 | 64 | 2.080 |
Why?
|
| Biliary Atresia | 3 | 2023 | 186 | 1.870 |
Why?
|
| Liver Failure, Acute | 4 | 2023 | 87 | 1.240 |
Why?
|
| Adenovirus Infections, Human | 2 | 2023 | 49 | 1.020 |
Why?
|
| Liver Cirrhosis | 4 | 2022 | 823 | 0.820 |
Why?
|
| Varicose Veins | 1 | 2022 | 28 | 0.820 |
Why?
|
| Hepatorenal Syndrome | 1 | 2022 | 27 | 0.810 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2022 | 64 | 0.800 |
Why?
|
| Hypertension, Portal | 1 | 2022 | 78 | 0.780 |
Why?
|
| Hepatic Artery | 3 | 2022 | 51 | 0.760 |
Why?
|
| Respiratory Insufficiency | 2 | 2022 | 232 | 0.750 |
Why?
|
| Gastroenterology | 1 | 2024 | 191 | 0.750 |
Why?
|
| Fellowships and Scholarships | 1 | 2024 | 271 | 0.740 |
Why?
|
| Bradycardia | 1 | 2020 | 59 | 0.710 |
Why?
|
| Dexmedetomidine | 1 | 2020 | 44 | 0.700 |
Why?
|
| Gastroenteritis | 1 | 2023 | 341 | 0.680 |
Why?
|
| Hypnotics and Sedatives | 1 | 2020 | 133 | 0.660 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2021 | 126 | 0.650 |
Why?
|
| Thrombosis | 3 | 2022 | 521 | 0.640 |
Why?
|
| Patient Admission | 1 | 2020 | 184 | 0.640 |
Why?
|
| Curriculum | 1 | 2024 | 719 | 0.620 |
Why?
|
| End Stage Liver Disease | 1 | 2020 | 178 | 0.590 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2017 | 16 | 0.560 |
Why?
|
| Liver | 2 | 2021 | 1734 | 0.530 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 387 | 0.530 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2017 | 243 | 0.490 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2017 | 224 | 0.480 |
Why?
|
| Pediatrics | 1 | 2024 | 1139 | 0.470 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 711 | 0.370 |
Why?
|
| Child | 10 | 2024 | 24244 | 0.320 |
Why?
|
| Infant | 8 | 2023 | 12347 | 0.310 |
Why?
|
| Postoperative Complications | 2 | 2021 | 3013 | 0.310 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 1806 | 0.310 |
Why?
|
| Retrospective Studies | 8 | 2024 | 16022 | 0.260 |
Why?
|
| Humans | 16 | 2024 | 123182 | 0.230 |
Why?
|
| Hospitalization | 3 | 2022 | 1736 | 0.230 |
Why?
|
| Peritonitis | 1 | 2022 | 76 | 0.200 |
Why?
|
| Ascites | 1 | 2022 | 87 | 0.200 |
Why?
|
| Adenoviruses, Human | 1 | 2022 | 80 | 0.200 |
Why?
|
| Hepatitis | 1 | 2022 | 59 | 0.200 |
Why?
|
| Hemochromatosis | 1 | 2021 | 32 | 0.190 |
Why?
|
| Antithrombins | 1 | 2021 | 56 | 0.180 |
Why?
|
| Waiting Lists | 1 | 2023 | 225 | 0.180 |
Why?
|
| Liver Failure | 1 | 2021 | 89 | 0.180 |
Why?
|
| International Normalized Ratio | 1 | 2020 | 42 | 0.170 |
Why?
|
| Aspartate Aminotransferases | 1 | 2020 | 76 | 0.170 |
Why?
|
| Venous Thrombosis | 1 | 2022 | 180 | 0.170 |
Why?
|
| Adenoviridae | 1 | 2023 | 605 | 0.170 |
Why?
|
| Forecasting | 1 | 2021 | 356 | 0.170 |
Why?
|
| Infant, Newborn | 4 | 2022 | 8106 | 0.170 |
Why?
|
| Child, Preschool | 4 | 2022 | 13889 | 0.170 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 507 | 0.160 |
Why?
|
| Multiple Organ Failure | 1 | 2020 | 140 | 0.160 |
Why?
|
| Creatinine | 1 | 2020 | 380 | 0.150 |
Why?
|
| Liver Diseases | 1 | 2022 | 362 | 0.150 |
Why?
|
| Peptide Fragments | 1 | 2021 | 748 | 0.140 |
Why?
|
| Philadelphia | 1 | 2017 | 25 | 0.140 |
Why?
|
| Clinical Competence | 1 | 2024 | 972 | 0.140 |
Why?
|
| Intensive Care Units | 1 | 2020 | 481 | 0.130 |
Why?
|
| Registries | 1 | 2023 | 1393 | 0.130 |
Why?
|
| Remission, Spontaneous | 1 | 2016 | 68 | 0.130 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2016 | 23 | 0.130 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2016 | 57 | 0.130 |
Why?
|
| Anticoagulants | 2 | 2022 | 583 | 0.130 |
Why?
|
| Early Diagnosis | 1 | 2016 | 180 | 0.120 |
Why?
|
| Hospital Mortality | 1 | 2020 | 1010 | 0.120 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 195 | 0.120 |
Why?
|
| Male | 5 | 2023 | 60083 | 0.120 |
Why?
|
| Secondary Prevention | 1 | 2016 | 212 | 0.120 |
Why?
|
| Length of Stay | 1 | 2020 | 1285 | 0.120 |
Why?
|
| Female | 4 | 2023 | 65494 | 0.110 |
Why?
|
| Recurrence | 1 | 2017 | 1422 | 0.110 |
Why?
|
| Hospitals, Pediatric | 1 | 2017 | 780 | 0.100 |
Why?
|
| Prognosis | 1 | 2020 | 4508 | 0.090 |
Why?
|
| Risk Factors | 2 | 2022 | 10021 | 0.080 |
Why?
|
| Heart Failure | 1 | 2022 | 2131 | 0.080 |
Why?
|
| Adolescent | 2 | 2017 | 19118 | 0.080 |
Why?
|
| Young Adult | 1 | 2017 | 8885 | 0.050 |
Why?
|
| Renal Replacement Therapy | 1 | 2024 | 141 | 0.050 |
Why?
|
| Portal Vein | 1 | 2022 | 91 | 0.050 |
Why?
|
| Viremia | 1 | 2022 | 126 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 89 | 0.050 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2021 | 27 | 0.050 |
Why?
|
| Hirudins | 1 | 2021 | 37 | 0.050 |
Why?
|
| Graft Survival | 1 | 2022 | 525 | 0.040 |
Why?
|
| Acute Disease | 1 | 2022 | 1092 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 1385 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2022 | 12129 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2801 | 0.030 |
Why?
|
| Adult | 1 | 2024 | 29065 | 0.010 |
Why?
|